Shengm Dai

Dr. Shengm Dai


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
XCXiaoli Chen
Xiaoli Chen
HCHankui Chen
Hankui Chen
MDMeiyu Dai
Meiyu Dai
JAJunmei Ai
Junmei Ai
YLYan Li
Yan Li
YDYouping Deng
Youping Deng
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions

5 February 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZPZheng Peng
Zheng Peng
YSYifan Sun
Yifan Sun
XLXiaolan Lv
Xiaolan Lv
HZHongyu Zhang
Hongyu Zhang
CLChunming Liu
Chunming Liu
SDShengm Dai
Shengm Dai
The change of serum interleukin-6(IL-6) levels in women with polycystic ovary syndrome (PCOS), as well as the relations between IL-6 levels and body mass index (BMI), insulin resistance(IR) and androgen status of PCOS patients, are not fully understood. A literature search was performed in October 2015 using PubMed, Embase and the Cochrane Library databases to identify studies. Random-effects model was used to estimate the standardized mean differences (SMDs) with 95% confidence intervals (CIs). Twenty articles with 25 case-control studies included 1618 women (922 PCOS patients and 696 controls) were included in this study. IL-6 levels in controls were significantly lower than that of PCOS patients (SMD = 0.78, 95%CI = 0.41–1.16, P<0.001), with significant heterogeneity across studies (I2 = 91% and P<0.001). Meta-regression analysis model indicated IR status was the main source of heterogeneity (P = 0.005). Results from group analysis suggested that high IL-6 levels in PCOS were significantly associated with Homeostasis Model Assessment of Insulin Resistance (HOMA2-IR) ratio and total testosterone ratio (T ratio), and was found in both lean and obese women with PCOS. Cumulative meta-analysis results indicated the total effect size (SMD) had tend to be stable since 2012(0.79 to 0.92). A high IL-6 level is not an intrinsic characteristic of PCOS, but may be a useful monitoring biomarker for the treatment of PCOS.

28 April 2016 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
XLXuexiang Liu
Xuexiang Liu
JLJinwan Li
Jinwan Li
FQFengxian Qin
Fengxian Qin
SDShengm Dai
Shengm Dai
MicroRNAs (miRNAs or miRs) are endogenous translation repressors of protein-coding genes that act by binding to the 3'-untranslated region of their target genes, and may contribute to tumorigenesis by functioning as oncogenes or tumor suppressor genes. miR‑152, a member of the miR-148/152 family, is aberrantly expressed in various diseases, including various types of cancer. A growing body of evidence has demonstrated that miR‑152 may act as a tumor suppressor gene by regulating its target genes, which are associated with cell proliferation, migration and invasion in human cancer. In the present review, the gene structure and functions of miR‑152 are discussed, and in particular, its regulatory mechanism, experimentally validated targets and tumor suppressor role in cancer, are highlighted.

13 April 2017 in Oncotarget
Verified
Journal Article
Open access
BHBaoyu He
Baoyu He
JZJianchao Zeng
Jianchao Zeng
WCWei Chao
Wei Chao
XCXiaoli Chen
Xiaoli Chen
YHYujie Huang
Yujie Huang
SDShengm Dai
Shengm Dai
Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma

13 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MDMeiyu Dai
Meiyu Dai
XCXiaoli Chen
Xiaoli Chen
SMShanying Mo
Shanying Mo
JLJinwan Li
Jinwan Li
ZHZhizhuo Huang
Zhizhuo Huang
SDShengm Dai
Shengm Dai
The aim of this study is to explore the differentially expressed lncRNAs, which may have potential biological function and diagnostic value in colorectal cancer (CRC). Through integrated data mining, we finally identified nine differentially expressed lncRNAs and their potential mRNA targets. After a series of bioinformatics analyses, we screened significant pathways and GO terms that are related to the up-regulated and down-regulated transcripts respectively. Meanwhile, the nine lncRNAs were validated in 30 paired tissues and cell lines by qRT-PCR and the results were basically consistent with the microarray data. We also tested the nine lncRNAs in the serum of 30 CRC patients matched with the CRC tissue, 30 non-cancer patients and 30 health controls. Finally, we found that BLACAT1 was significant for the diagnosis of CRC. The area under the curve (AUC), sensitivity and specificity were 0.858 (95% CI: 0.765–0.951), 83.3% and 76.7% respectively between CRC patients and health controls. Moreover, BLACAT1 also had distinct value to discriminate CRC from other non-cancer diseases. The results indicated that the differentially expressed lncRNAs and their potential target transcripts could be considered as potential therapeutic targets for CRC patients. Meanwhile, lncRNA BLACAT1 might represent a new supplementary biomarker for the diagnosis of CRC.

6 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMeiyu Dai
Meiyu Dai
XCXiaoli Chen
Xiaoli Chen
XLXuexiang Liu
Xuexiang Liu
ZPZheng Peng
Zheng Peng
JMJie Meng
Jie Meng
SDShengm Dai
Shengm Dai
Conflicting results have been widely reported on the use of Golgi protein 73 (GP73) as a serum biomarker for diagnosing hepatocellular carcinoma (HCC). This study evaluated the accuracy of GP73, alpha-fetoprotein (AFP), and GP73 + AFP for diagnosing HCC. The meta-analysis was performed on 11 studies that were selected by means of a comprehensive systematic literature review. Summary diagnostic accuracy, meta-regression analysis for heterogeneity and publication bias, and other statistical analyses were performed using Meta-Disc (version 1.4) and Stata (version 12.0). Pooled sensitivity, specificity, and diagnostic odds ratio were 0.77 (95% CI: 0.75–0.79), 0.91 (95% CI: 0.90–0.92), and 12.49 (95% CI: 4.91–31.79) for GP73; 0.62 (95% CI: 0.60–0.64), 0.84 (95% CI: 0.83–0.85), and 11.61 (95% CI: 8.02–16.81) for AFP; and 0.87 (95% CI: 0.85–0.89), 0.85 (95% CI: 0.84–0.86), and 30.63 (95% CI: 18.10–51.84) for GP73 + AFP. The area under the curve values were 0.86, 0.84, and 0.91 for GP73, AFP, and GP73 + AFP, respectively. These results indicate that for HCC diagnosis, the accuracy of GP73 was higher than that of AFP, and that GP73 + AFP exhibited significantly higher diagnostic accuracy than did GP73 or AFP alone.